Uta Kiltz, PhD

Rheumazentrum Ruhrgebiet
D-44649 Herne, Germany

Dr Uta Kiltz gained her MD in 1997 from Ruhr University Bochum, Germany. Currently, Dr Kiltz is working as a rheumatologist in Rheumazentrum Ruhrgebiet, Germany. Her main area of interest is in the field of spondyloarthritis, focusing especially on patient-reported outcomes and quality of care.

Disclosure information not submitted.

Presentation(s):

0084: Facilitators and Barriers of Vaccine Uptake in Patients with Chronic Inflammatory Rheumatic Disease: A Scoping Review
Saturday, November 12, 2022
1:00 PM – 3:00 PM Eastern Time
0395: How Does Body Mass Index Affect Secukinumab Treatment Outcomes and Safety in Patients with Psoriatic Arthritis? - Real World Data from a German Observational Study
Saturday, November 12, 2022
1:00 PM – 3:00 PM Eastern Time
0907: Identifying Trajectories of Remission in Patients with Rheumatoid Arthritis Treated in a Tertiary Care Centre
Sunday, November 13, 2022
9:00 AM – 10:30 AM Eastern Time
1013: Discriminatory Capacity of the ASAS Health Index in Patients with Axial Spondyloarthritis Treated in a Tight Control Setting versus Standard of Care
Sunday, November 13, 2022
9:00 AM – 10:30 AM Eastern Time
1040: Impact of Weight and Sex on Long-term Persistence to Secukinumab Treatment in Patients with Active Psoriatic Arthritis or Ankylosing Spondylitis
Sunday, November 13, 2022
9:00 AM – 10:30 AM Eastern Time
1495: How Does Body Mass Index Affect Secukinumab Treatment Outcomes and Safety in Patients with Ankylosing Spondylitis? – Real World Data from a German Observational Study
Sunday, November 13, 2022
1:00 PM – 3:00 PM Eastern Time
1497: How Does Time to Diagnosis and Gender Affect Treatment Outcomes in Patients with Ankylosing Spondylitis or Psoriatic Arthritis? - Real World Data from a German Observational Study with Secukinumab
Sunday, November 13, 2022
1:00 PM – 3:00 PM Eastern Time